Stock Events

Stock Events

Nexalin Technology

$0.01

35

+$0+2.22% Friday 19:18

Statistics

Day High

0.01

Day Low

0.01

52W High

0.01

52W Low

0.01

Volume

121,671

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

3JunExpected

Q3 2024

Q4 2024

Q1 2025

Q2 2025

Q3 2025

Q4 2025

Next

-0.25

-0.2

-0.15

-0.1

Expected EPS

-0.1

Actual EPS

N/A

Financials

-4,501.18%Profit Margin

Unprofitable

2020

2021

2022

2023

2024

169,000Revenue

-7.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NXLIW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Zimmer Biomet Holdings, Inc. competes in the medical devices sector, offering products that could be seen as alternatives to Nexalin's technology for treating conditions like anxiety and depression.

Medtronic plc is a global leader in medical technology, services, and solutions, including neuromodulation devices that compete with Nexalin's offerings.

Abbott Laboratories

Abbott Laboratories operates in various segments, including neuromodulation, making it a competitor in the market for therapeutic devices similar to Nexalin's.

Boston Scientific

Boston Scientific Corporation is involved in the development, manufacturing, and marketing of medical devices that compete in the neuromodulation space.

Smith & Nephew plc offers medical devices that can be used in treatments that compete with Nexalin's technology, particularly in the area of pain management and rehabilitation.

Stryker Corporation is a technology company that offers products in medical and surgical, which could compete with Nexalin's approach to treating neurological conditions.

Edwards Lifesciences

Edwards Lifesciences Corporation is known for its innovations in patient-focused medical technologies, including those that could compete with Nexalin's neuromodulation devices.

Integra Lifesciences

Integra LifeSciences Holdings Corporation offers products in neurosurgery and other medical device areas, potentially competing with Nexalin's technology.

Globus Medical, Inc. is engaged in the design, development, and commercialization of musculoskeletal solutions, which may indirectly compete with Nexalin's neuromodulation therapies for pain management.

About

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.

Show more...

CEO

Mr. Mark White

Employees

6

Country

United States

ISIN

US65345B2016

Listings

0 Comments

Share your thoughts

FAQ

What is Nexalin Technology stock price today?▼

The current price of NXLIW is $0.01 USD — it has increased by +2.22% in the past 24 hours. Watch Nexalin Technology stock price performance more closely on the chart.

What is Nexalin Technology stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Nexalin Technology stocks are traded under the ticker NXLIW.

Is Nexalin Technology stock price growing?▼

NXLIW stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Nexalin Technology has showed a -81.65% decrease.

What is Nexalin Technology revenue for the last year?▼

Nexalin Technology revenue for the last year amounts to 169,000 USD.

What is Nexalin Technology net income for the last year?▼

NXLIW net income for the last year is -7.61M USD.

How many employees does Nexalin Technology have?▼

As of April 14, 2026, the company has 6 employees.

In which sector is Nexalin Technology located?▼

Nexalin Technology operates in the Health & Wellness sector.

When did Nexalin Technology complete a stock split?▼

Nexalin Technology has not had any recent stock splits.

Where is Nexalin Technology headquartered?▼

Nexalin Technology is headquartered in Houston, United States.